Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study.
about
Prognostic molecular markers in early breast canceruPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.Urokinase expression by tumor suppressor protein p53: a novel role in mRNA turnover.Induction of p53 by urokinase in lung epithelial cells.Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells.
P2860
Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Prognostic value of uPA and p5 ...... patients: a multicentre study.
@ast
Prognostic value of uPA and p5 ...... patients: a multicentre study.
@en
type
label
Prognostic value of uPA and p5 ...... patients: a multicentre study.
@ast
Prognostic value of uPA and p5 ...... patients: a multicentre study.
@en
prefLabel
Prognostic value of uPA and p5 ...... patients: a multicentre study.
@ast
Prognostic value of uPA and p5 ...... patients: a multicentre study.
@en
P2093
P2860
P356
P1476
Prognostic value of uPA and p5 ...... patients: a multicentre study
@en
P2093
Asselain B
Ricolleau G
Spyratos F
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690389
P407
P577
1999-05-01T00:00:00Z